Log in
Enquire now
‌

US Patent 11873336 Heavy chain antibodies binding to CD22

Patent 11873336 was granted and assigned to TeneoBio on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
TeneoBio
TeneoBio
0
Current Assignee
TeneoBio
TeneoBio
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
118733360
Patent Inventor Names
Heather Anne N. Ogana0
Shelley Force Aldred0
Katherine Harris0
Nathan D. Trinklein0
Laura Marie Davison0
Udaya Rangaswamy0
Wim van Schooten0
Date of Patent
January 16, 2024
0
Patent Application Number
169565020
Date Filed
December 21, 2018
0
Patent Citations
‌
US Patent 9034324 Anti-BCMA antibodies
0
‌
US Patent 7541513 Mouse λ light chain locus
0
‌
US Patent 8367888 Mouse λ light chain locus
0
‌
US Patent 8883150 Soluble “heavy-chain only” antibodies
0
‌
US Patent 9365655 Soluble heavy-chain only antibodies
0
Patent Primary Examiner
‌
Karen A. Canella
0
CPC Code
‌
C07K 2317/569
0
Patent abstract

Anti-CD22 heavy chain antibodies (e.g., UniAbs™) are disclosed, along with methods of making such antibodies, compositions, including pharmaceutical compositions, comprising such antibodies, and their use to treat B cell disorders that are characterized by the expression of CD22.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11873336 Heavy chain antibodies binding to CD22

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.